South Korean food companies will start selling not-so-spicy ‘mild kimchi’ products in the US and Europe to increase their presence in those markets.
Daesang Corp. recently invested 20 billion won in putting up a manufacturing plant in Los Angeles that could annually produce around 2,000 tons of mild kimchi in two types: one with salted seafood, and a ‘vegan’ style without it.
CJ Cheiljedang Corp., which is also making mild kimchi consisting of plant-based ingredients recipes without salted seafood, also plans to expand exports. It will enter H Mart, a US supermarket chain operating some 70 stores throughout the country, and set up a branch office in England for the European market.
Meanwhile, Sempio Foods Company has released two canned kimchi products, ‘Kimchi Original’ and ‘Stir-fried Kimchi,’ using the ‘yondu’ bean-based liquid seasoning instead of using fish sauce. It would be sold in the US and Europe.
Yondu helps create deep flavors while catering to the needs of vegetarians.


SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Canada’s local food system faces major roadblocks without urgent policy changes
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
How to support someone who is grieving: five research-backed strategies
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
S&P 500 Rises as AI Stocks and Small Caps Rally on Strong Earnings Outlook
UK Employers Plan Moderate Pay Rises as Inflation Pressures Ease but Persist
Parents abused by their children often suffer in silence – specialist therapy is helping them find a voice
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
Why have so few atrocities ever been recognised as genocide?
EU Recovery Fund Faces Bottlenecks Despite Driving Digital and Green Projects 



